Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib
- Author
- CURIGLIANO, Giuseppe1 ; PELOSI, Giuseppe2 3 ; DE PAS, Tommaso1 ; RENNE, Giuseppe2 ; DE COBELLI, Ottavio4 ; MANZOTTI, Michela2 ; SPITALERI, Gianluca1 ; DE BRAUD, Filippo1
[1] Division of Medical Oncology, Clinical Pharmacology and New Drugs Development Unit, European Institute of Oncology and University of Milan School of Medicine, Milano, Italy
[2] Division of Pathology, European Institute of Oncology and University of Milan School of Medicine, Milano, Italy
[3] European Institute of Oncology and University of Milan School of Medicine, Milano, Italy
[4] Division of Urology, European Institute of Oncology and University of Milan School of Medicine, Milano, Italy - Source
The Prostate. 2007, Vol 67, Num 6, pp 603-604, 2 p ; ref : 5 ref
- CODEN
- PRSTDS
- ISSN
- 0270-4137
- Scientific domain
- Obstetrics, gynecology, andrology; Urology, nephrology
- Publisher
- Wiley-Liss, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- EGFR mutations gefitinib prostate cancer
- Keyword (fr)
- Andrologie Anticancéreux Cancer prostate Communication Gynécologie Gène Géfitinib Génétique Homme Mutation Récepteur facteur croissance épiderme Récepteur facteur croissance Résistance traitement Traitement hormonal Inhibiteur de la tyrosine kinase Néphrologie Appareil génital mâle pathologie Appareil urinaire pathologie Enzyme Inhibiteur enzyme Prostate pathologie Protein-tyrosine kinase Quinazoline dérivé Transferases Tumeur maligne
- Keyword (en)
- Andrology Antineoplastic agent Prostate cancer Communication Gynecology Gene Gefitinib Genetics Human Mutation Epidermal growth factor receptor Growth factor receptor Treatment resistance Hormone therapy Nephrology Male genital diseases Urinary system disease Enzyme Enzyme inhibitor Prostate disease Protein-tyrosine kinase Quinazoline derivatives Transferases Malignant tumor
- Keyword (es)
- Andrología Anticanceroso Cáncer de la próstata Comunicación Ginecología Gen Gefitinib Genética Hombre Mutación Receptor factor crecimiento epidermi Receptor factor crecimiento Resistencia tratamiento Hormonoterapia Nefrología Aparato genital macho patología Aparato urinario patología Enzima Inhibidor enzima Prostata patología Protein-tyrosine kinase Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D02 Urinary tract. Prostate gland
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20B Male genital diseases / 002B20B02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Nephrology. Urinary tract diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18701938
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/pros.20530 
https://dx.doi.org/10.1002/pros.20530
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/pros.20530\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:9:\"\u0000*\u0000jtitle\";s:12:\"The Prostate\";s:9:\"\u0000*\u0000stitle\";s:8:\"Prostate\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"603\";s:8:\"\u0000*\u0000epage\";s:3:\"604\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0270-4137\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"CURIGLIANO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giuseppe\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"PELOSI, Giuseppe\";i:1;s:15:\"DE PAS, Tommaso\";i:2;s:15:\"RENNE, Giuseppe\";i:3;s:19:\"DE COBELLI, Ottavio\";i:4;s:17:\"MANZOTTI, Michela\";i:5;s:19:\"SPITALERI, Gianluca\";i:6;s:17:\"DE BRAUD, Filippo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PRSTDS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"2\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/pros.20530\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:9:\"\u0000*\u0000jtitle\";s:12:\"The Prostate\";s:9:\"\u0000*\u0000stitle\";s:8:\"Prostate\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"603\";s:8:\"\u0000*\u0000epage\";s:3:\"604\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0270-4137\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"CURIGLIANO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giuseppe\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"PELOSI, Giuseppe\";i:1;s:15:\"DE PAS, Tommaso\";i:2;s:15:\"RENNE, Giuseppe\";i:3;s:19:\"DE COBELLI, Ottavio\";i:4;s:17:\"MANZOTTI, Michela\";i:5;s:19:\"SPITALERI, Gianluca\";i:6;s:17:\"DE BRAUD, Filippo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PRSTDS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"2\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/pros.20530\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/pros.20530\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:9:\"\u0000*\u0000jtitle\";s:12:\"The Prostate\";s:9:\"\u0000*\u0000stitle\";s:8:\"Prostate\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"603\";s:8:\"\u0000*\u0000epage\";s:3:\"604\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0270-4137\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"CURIGLIANO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giuseppe\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"PELOSI, Giuseppe\";i:1;s:15:\"DE PAS, Tommaso\";i:2;s:15:\"RENNE, Giuseppe\";i:3;s:19:\"DE COBELLI, Ottavio\";i:4;s:17:\"MANZOTTI, Michela\";i:5;s:19:\"SPITALERI, Gianluca\";i:6;s:17:\"DE BRAUD, Filippo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PRSTDS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"2\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/pros.20530\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:9:\"\u0000*\u0000jtitle\";s:12:\"The Prostate\";s:9:\"\u0000*\u0000stitle\";s:8:\"Prostate\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"603\";s:8:\"\u0000*\u0000epage\";s:3:\"604\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0270-4137\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"CURIGLIANO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giuseppe\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"PELOSI, Giuseppe\";i:1;s:15:\"DE PAS, Tommaso\";i:2;s:15:\"RENNE, Giuseppe\";i:3;s:19:\"DE COBELLI, Ottavio\";i:4;s:17:\"MANZOTTI, Michela\";i:5;s:19:\"SPITALERI, Gianluca\";i:6;s:17:\"DE BRAUD, Filippo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PRSTDS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"2\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/pros.20530\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:9:\"\u0000*\u0000jtitle\";s:12:\"The Prostate\";s:9:\"\u0000*\u0000stitle\";s:8:\"Prostate\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"67\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"603\";s:8:\"\u0000*\u0000epage\";s:3:\"604\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0270-4137\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"CURIGLIANO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Giuseppe\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"PELOSI, Giuseppe\";i:1;s:15:\"DE PAS, Tommaso\";i:2;s:15:\"RENNE, Giuseppe\";i:3;s:19:\"DE COBELLI, Ottavio\";i:4;s:17:\"MANZOTTI, Michela\";i:5;s:19:\"SPITALERI, Gianluca\";i:6;s:17:\"DE BRAUD, Filippo\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PRSTDS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:158:\"Rapid communication absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"2\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
